Effects of angiotensin II on expression of the gap junction channel protein connexin43 in neonatal rat ventricular myocytes

Journal of the American College of Cardiology

Volumn 32, Issue 3, 1998, Pages 800-807

  Dodge, Stephen M ^a   Beardslee, Michael A ^a   Darrow, Bruce J ^a   Green, Karen G ^a   Beyer, Eric C ^a   Saffitz, Jeffrey E ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; CONNEXIN 43; GAP JUNCTION PROTEIN; LOSARTAN;

ANIMAL CELL; ARTICLE; CELL ULTRASTRUCTURE; CONFOCAL MICROSCOPY; GAP JUNCTION; HEART HYPERTROPHY; HEART MUSCLE CELL; HEART VENTRICLE ARRHYTHMIA; IMMUNOBLOTTING; IMMUNOREACTIVITY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RAT; REENTRY TACHYCARDIA; SIGNAL TRANSDUCTION;

ANGIOTENSIN II; ANIMALS; ANIMALS, NEWBORN; CARDIOMEGALY; CONNEXIN 43; CULTURE TECHNIQUES; GAP JUNCTIONS; HEART VENTRICLES; MICROSCOPY, CONFOCAL; MICROSCOPY, ELECTRON; MICROSCOPY, FLUORESCENCE; RATS; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 0031671378     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(98)00317-9     Document Type: Article

References (37)

1. Dillon S.M., Allessie M.A., Ursell P.C., Wit A.L. Influences of anisotropic tissue structure on reentrant circuits in the epicardial border zone of subacute canine infarcts. Circ Res. 63:1988;182-206.
2. Peters N.S., Coromilas J., Severs N.J., Wit A.L. Disturbed connexin43 gap junction distribution correlates with the location of reentrant circuits in the epicardial border zone of healing canine infarcts that cause ventricular tachycardia. Circulation. 95:1997;988-996.
3. Gardner P.I., Ursell P.C., Fenoglio J.J., Wit A.L. Electrophysiologic and anatomic basis for fractionated electrograms recorded from healed myocardial infarcts. Circulation. 72:1985;596-611.
4. Ursell P.C., Gardner P.I., Albala A., Fenoglio J.J., Wit A.L. Structural and electrophysiological changes in the epicardial border zone of canine myocardial infarcts during infarct healing. Circ Res. 56:1985;436-451.
5. Luke R.A., Saffitz J.E. Remodeling of ventricular conduction pathways in healed canine infarct border zones. J Clin Invest. 87:1991;1594-1602.
6. de Bakker J.M.T., van Capelle F.J.L., Janse M.J., et al. Slow conduction in the infarcted human heart "zigzag" course of activation . Circulation. 88:1993;915-926.
7. Smith J.H., Green C.R., Peters N.S., Rothery S., Severs N.J. Altered patterns of gap junction distribution in ischemic heart disease an immunohistochemical study of human myocardium using laser scanning confocal microscopy . Am J Pathol. 139:1991;801-821.
8. Pfeffer M.A., Braunwald E. Ventricular remodeling after myocardial infarction experimental observations and clinical implications . Circulation. 81:1990;1161-1172.
9. Weber K.T., Anversa P., Armstrong P.W., et al. Remodeling and reparation of the cardiovascular system. J Am Coll Cardiol. 20:1992;3-16.
10. Konstam M.A. Role of angiotensin converting enzyme inhibitors in preventing left ventricular remodelling following myocardial infarction. Eur J Cardiol. 16:(Suppl K):1995;42-48.
11. Baufarb I.S., Sonnenblick E.H. The renin-angiotensin system in left ventricular remodeling. Am J Cardiol. 77:1996;8C-16C.
12. Effects of enalapril on mortality in severe congestive heart failure - results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med. 23:1987;1429-1435.
13. Pfeffer M.A., Lamas G.A., Vaughan D.E., Parisi A.F., Braunwald E. Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction. N Engl J Med. 319:1988;80-86.
14. Sharpe N., Smith H., Murphy J., Hannan S. Treatment of patients with symptomless left ventricular dysfunction after myocardial infarction. Lancet. 1:1988;255-259.
15. Pfeffer M.A., Braunwald E., Moye L.A., et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction [SAVE]. N Engl J Med. 327:1991;669-677.
16. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet. 342:1993;821-827.
17. Ambrosioni E, Borghi C, Magnani B, for the SMILE Investigators. The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. N Engl J Med 1995;332:80-5.
18. Baker K.M., Aceto J.F. Angiotensin II stimulation of protein synthesis and cell growth in chick heart cells. Am J Physiol. 259:1990;H610-H618.
19. Sadoshima J., Xu Y., Slayter H.S., Izumo S. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell. 75:1993;977-984.
20. Sadoshima J., Izumo S. Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts critical role of the AT1 receptor subtype . Circ Res. 73:1993;413-423.
21. Neyses L., Nouskas J., Luyken J., et al. Induction of immediate-early genes by angiotensin II and endothelin-1 in adult rat cardiomyocytes. J Hypertens. 11:1993;927-934.
22. Miyata S., Haneda T. Hypertrophic growth of cultured neonatal rat heart cells mediated by type 1 angiotensin II receptor. Am J Physiol. 266:1994;H2443-H2451.
23. 2+-dependent signaling . Circ Res. 76:1995;1-5.
24. Darrow B.J., Fast V.G., Kléber A.G., Beyer E.C., Saffitz J.E. Functional and structural assessment of intercellular communication increased conduction velocity and enhanced connexin expression in dibutyryl cAMP-treated cultured cardiac myocytes . Circ Res. 79:1996;174-183.
25. Darrow B.J., Laing J.G., Lampe P.D., Saffitz J.E., Beyer E.C. Expression of multiple connexins in cultured neonatal rat ventricular myocytes. Circ Res. 76:1995;381-387.
26. Guerrero P.A., Schuessler R.B., Davis L.M., et al. Slow ventricular conduction in mice heterozygous for a Cx43 null mutation. J Clin Invest. 99:1997;1991-1998.
27. Musil L.S., Goodenough D.A. Biochemical analysis of connexin43 intracellular transport, phosphorylation, and assembly into gap junctional plaques. J Cell Biol. 115:1991;1357-1374.
28. Nagy J.I., Li W.E., Roy C., et al. Selective monoclonal antibody recognition and cellular localization of an unphosphorylated form of connexin43. Exp Cell Res. 236:1997;127-136.
29. Laird D.W., Puranam K.L., Revel J.P. Turnover and phosphorylation dynamics of connexin43 gap junction protein in cultured cardiac myocytes. Biochem J. 273:1991;67-72.
30. Cohn J.N., Johnson G., Ziesche S., et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure [V-HeFT]. N Engl J Med. 5:1991;303-310.
31. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 325:1991;293-302.
32. Khairallah P.A., Kanabus J. Angiotensin and myocardial protein synthesis. Tarazi R.C. Perspectives of cardiovascular research. 1983;337-347 Raven Press, New York.
33. Baker K.M., Chernin M.I., Wixson S.K., Aceto J.F. Renin-angiotensin system involvement in pressure-overload cardiac hypertrophy in rats. Am J Physiol. 259:1990;H324-H332.
34. Brilla C.G., Zhou G., Matsubara L., Weber K.T. Collagen metabolism in cultured adult rat cardiac fibroblasts response to angiotensin II and aldosterone . J Mol Cell Cardiol. 26:1994;809-820.
35. Harada M., Itoh N., Nakagawa O., et al. Significance of ventricular myocytes and nonmyocytes interaction during cardiocyte hypertrophy Evidence for endothelin-1 as a paracrine hypertrophic factor from cardiac nonmyocytes . Circulation. 96:1997;3737-3744.
36. Sáez J.C., Gregory W.A., Watanabe T., et al. cAMP delays disappearance of gap junctions between pairs of rat hepatocytes in primary culture. Am J Physiol. 257:1989;C1-C11.
37. Fallon R., Goodenough D.A. Five-hour half-life of mouse liver gap junction proteins. J Cell Biol. 90:1981;521-526.